Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer H Tonbul, A Sahin, E Tavukcuoglu, G Esendagli, Y Capan Journal of Drug Delivery Science and Technology 54, 101380, 2019 | 38 | 2019 |
Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells H Tonbul, A Sahin, E Tavukcuoglu, G Ultav, S Akbas, Y Aktas, ... Journal of Drug Delivery Science and Technology 63, 102535, 2021 | 23 | 2021 |
Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier I Seko, H Tonbul, E Tavukçuoğlu, A Şahin, S Akbas, H Yanık, SC Öztürk, ... Journal of Drug Delivery Science and Technology 66, 102867, 2021 | 13 | 2021 |
Brain-targeted nanoparticles to overcome the blood-brain barrier S Indrit, A Şahin, H Tonbul, Y Çapan Journal of Pharmaceutical Technology 1 (1), 25-39, 2020 | 10 | 2020 |
Independent predictive factors for the persistence and tolerance of cow's milk allergy E Topal, MH Çeliksoy, M Arga, MS Kaynak, Y Duman, S Demirtaş, ... International Forum of Allergy & Rhinology 9 (1), 67-71, 2019 | 10 | 2019 |
pH-sensitive chitosan-PEG-decorated hollow mesoporous silica nanoparticles could be an effective treatment for acute myeloid leukemia (AML) G Ultav, H Tonbul, E Tavukcuoglu, SC Ozturk, S Akbas, A Sahin, ... Journal of Nanoparticle Research 24 (2), 40, 2022 | 5 | 2022 |
Development of paclitaxel and flurbiprofen coloaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett–Burman design A Sahin, S Caban-Toktas, H Tonbul, F Yerlikaya, Y Aktas, Y Capan Istanbul Journal of Pharmacy 49 (3), 161-166, 2019 | 5 | 2019 |
Synthesis of small-sized mesoporous silica nanoparticles by experimental design and characterization for further drug delivery H Tonbul, G Ultav, S AKBAŞ, A Sahin, Y AKTAŞ, Y Capan Latin American Journal of Pharmacy 38 (11), 2019 | 5 | 2019 |
An effective VEGF-siRNA delivery via folic acid decorated and pegylated silica nanoparticles G Ultav, H Tonbul, E Salva Journal of Drug Delivery Science and Technology 76, 103828, 2022 | 4 | 2022 |
Drug Delivery with Targeted Nanoparticles: In Vitro and In Vivo Evaluation Methods Y Çapan, A Sahin, H Tonbul CRC Press, 2021 | 3 | 2021 |
Overcoming the challenges of drug resistance through combination drug delivery approach H Tonbul, A Şahin, Y Çapan Combination Drug Delivery Approach as an Effective Therapy for Various …, 2022 | 2 | 2022 |
Evaluation of Targeted Mesoporous Silica Nanoparticles H Tonbul Drug Delivery with Targeted Nanoparticles, 643-656, 2021 | 2 | 2021 |
Hybrid PLGA nanoparticles as advanced drug delivery and theranostic applications H Tonbul, Y Çapan Poly (lactic-co-glycolic acid)(PLGA) Nanoparticles for Drug Delivery, 417-431, 2023 | 1 | 2023 |
Silica nanoparticle synthesis by experimental design for drug and gene delivery applications G Ultav, H TONBUL, A ŞAHİN, Y ÇAPAN Journal of research in pharmacy (online) 27 (1), 2023 | 1 | 2023 |
Demographics and clinical characteristic of patients diagnosed with hen’s egg allergy E Topal, M Arga, MH Celiksoy, MS Kaynak, Y Duman, S Demirtas, ... | 1 | 2019 |
Development of Silica Nanoparticles as a Delivery System for Plasmid-Based Crispr/Cas9 G ULTAV, MAC Kubra, S KİZİLBOGA, V GUNDOGDU, H TONBUL, ... Anatolian Journal of Pharmaceutical Sciences 1 (1), 33-39, 2022 | | 2022 |
An effective VEGF-siRNA delivery via folic acid decorated and pegylated G Ultav, H Tonbul, E Salva | | 2022 |
pH-sensitive chitosan-PEG-decorated hollow mesoporous silica G Ultav, H Tonbul, E Tavukcuoglu, SC Ozturk, S Akbas, A Sahin, ... | | 2022 |
Regulatory Guidelines of the US Food and Drug Administration and the European Medicines Agency for Actively Targeted Nanomedicines HC Çetintaş, H Tonbul, A Şahin, Y Çapan Drug Delivery with Targeted Nanoparticles, 725-741, 2021 | | 2021 |
Characteristics of Marketed Nanopharmaceutics E Şalva, H Tonbul Drug Delivery with Targeted Nanoparticles, 705-724, 2021 | | 2021 |